Targovax Receives 2017 Nordic Stars Award

Targovax Receives 2017 Nordic Stars Award Oslo, Norway, 14 September 2017: Targovax ASA (“Targovax” or “the Company”; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces...